Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 2003 May;58(Suppl 2):ii29–ii38. doi: 10.1136/thorax.58.suppl_2.ii29

BTS guidelines for the management of malignant pleural effusions

G Antunes, E Neville, J Duffy, N Ali
PMCID: PMC1766015  PMID: 12728148

Full Text

The Full Text of this article is available as a PDF (217.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aasebø U., Norum J., Sager G., Slørdal L. Intrapleurally instilled mitoxantrone in metastatic pleural effusions: a phase II study. J Chemother. 1997 Apr;9(2):106–111. doi: 10.1179/joc.1997.9.2.106. [DOI] [PubMed] [Google Scholar]
  2. Abbruzzese J. L., Abbruzzese M. C., Hess K. R., Raber M. N., Lenzi R., Frost P. Unknown primary carcinoma: natural history and prognostic factors in 657 consecutive patients. J Clin Oncol. 1994 Jun;12(6):1272–1280. doi: 10.1200/JCO.1994.12.6.1272. [DOI] [PubMed] [Google Scholar]
  3. Adler R. H., Sayek I. Treatment of malignant pleural effusion: a method using tube thoracostomy and talc. Ann Thorac Surg. 1976 Jul;22(1):8–15. doi: 10.1016/s0003-4975(10)63944-6. [DOI] [PubMed] [Google Scholar]
  4. Alberts D. S., Chen H. S., Mayersohn M., Perrier D., Moon T. E., Gross J. F. Bleomycin pharmacokinetics in man. II. Intracavitary administration. Cancer Chemother Pharmacol. 1979;2(2):127–132. doi: 10.1007/BF00254085. [DOI] [PubMed] [Google Scholar]
  5. Anderson C. B., Philpott G. W., Ferguson T. B. The treatment of malignant pleural effusions. Cancer. 1974 Apr;33(4):916–922. doi: 10.1002/1097-0142(197404)33:4<916::aid-cncr2820330405>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
  6. Antony V. B. Pathogenesis of malignant pleural effusions and talc pleurodesis. Pneumologie. 1999 Oct;53(10):493–498. doi: 10.1055/s-1999-9040. [DOI] [PubMed] [Google Scholar]
  7. Antony V. B., Rothfuss K. J., Godbey S. W., Sparks J. A., Hott J. W. Mechanism of tetracycline-hydrochloride-induced pleurodesis. Tetracycline-hydrochloride-stimulated mesothelial cells produce a growth-factor-like activity for fibroblasts. Am Rev Respir Dis. 1992 Oct;146(4):1009–1013. doi: 10.1164/ajrccm/146.4.1009. [DOI] [PubMed] [Google Scholar]
  8. Bayly T. C., Kisner D. L., Sybert A., Macdonald J. S., Tsou E., Schein P. S. Tetracycline and quinacrine in the control of malignant pleural effusions. A randomized trial. Cancer. 1978 Mar;41(3):1188–1192. doi: 10.1002/1097-0142(197803)41:3<1188::aid-cncr2820410357>3.0.co;2-o. [DOI] [PubMed] [Google Scholar]
  9. Berger R. L., Dargan E. L., Huang B. L. Dissemination of cancer cells by needle biopsy of the lung. J Thorac Cardiovasc Surg. 1972 Mar;63(3):430–432. [PubMed] [Google Scholar]
  10. Bilaçeroğlu S., Cağirici U., Perim K., Ozacar R. Corynebacterium parvum pleurodesis and survival is not significantly influenced by pleural pH and glucose level. Monaldi Arch Chest Dis. 1998 Feb;53(1):14–22. [PubMed] [Google Scholar]
  11. Bitran J. D., Brown C., Desser R. K., Kozloff M. F., Shapiro C., Billings A. A. Intracavitary bleomycin for the control of malignant effusions. J Surg Oncol. 1981;16(3):273–277. doi: 10.1002/jso.2930160312. [DOI] [PubMed] [Google Scholar]
  12. Bonnefoi H., Smith I. E. How should cancer presenting as a malignant pleural effusion be managed? Br J Cancer. 1996 Sep;74(5):832–835. doi: 10.1038/bjc.1996.444. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Boutin C., Rey F., Viallat J. R. Prevention of malignant seeding after invasive diagnostic procedures in patients with pleural mesothelioma. A randomized trial of local radiotherapy. Chest. 1995 Sep;108(3):754–758. doi: 10.1378/chest.108.3.754. [DOI] [PubMed] [Google Scholar]
  14. Cantó A., Blasco E., Casillas M., Zarza A. G., Padilla J., Pastor J., Tarazona V., París F. Thoracoscopy in the diagnosis of pleural effusion. Thorax. 1977 Oct;32(5):550–554. doi: 10.1136/thx.32.5.550. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Chernow B., Sahn S. A. Carcinomatous involvement of the pleura: an analysis of 96 patients. Am J Med. 1977 Nov;63(5):695–702. doi: 10.1016/0002-9343(77)90154-1. [DOI] [PubMed] [Google Scholar]
  16. Clementsen P., Evald T., Grode G., Hansen M., Krag Jacobsen G., Faurschou P. Treatment of malignant pleural effusion: pleurodesis using a small percutaneous catheter. A prospective randomized study. Respir Med. 1998 Mar;92(3):593–596. doi: 10.1016/s0954-6111(98)90315-8. [DOI] [PubMed] [Google Scholar]
  17. Colt H. G. Therapeutic thoracoscopy. Clin Chest Med. 1998 Jun;19(2):383–394. doi: 10.1016/s0272-5231(05)70085-x. [DOI] [PubMed] [Google Scholar]
  18. Davies C. W., Traill Z. C., Gleeson F. V., Davies R. J. Intrapleural streptokinase in the management of malignant multiloculated pleural effusions. Chest. 1999 Mar;115(3):729–733. doi: 10.1378/chest.115.3.729. [DOI] [PubMed] [Google Scholar]
  19. Davis M., Williford S., Muss H. B., White D. R., Cooper M. R., Jackson D. V., Barrett R. A phase I-II study of recombinant intrapleural alpha interferon in malignant pleural effusions. Am J Clin Oncol. 1992 Aug;15(4):328–330. doi: 10.1097/00000421-199208000-00011. [DOI] [PubMed] [Google Scholar]
  20. DiBonito L., Falconieri G., Colautti I., Bonifacio D., Dudine S. The positive pleural effusion. A retrospective study of cytopathologic diagnoses with autopsy confirmation. Acta Cytol. 1992 May-Jun;36(3):329–332. [PubMed] [Google Scholar]
  21. Dryzer S. R., Allen M. L., Strange C., Sahn S. A. A comparison of rotation and nonrotation in tetracycline pleurodesis. Chest. 1993 Dec;104(6):1763–1766. doi: 10.1378/chest.104.6.1763. [DOI] [PubMed] [Google Scholar]
  22. Dumire R., Crabbe M. M., Mappin F. G., Fontenelle L. J. Autologous "blood patch" pleurodesis for persistent pulmonary air leak. Chest. 1992 Jan;101(1):64–66. doi: 10.1378/chest.101.1.64. [DOI] [PubMed] [Google Scholar]
  23. Evans T. R., Stein R. C., Pepper J. R., Gazet J. C., Ford H. T., Coombes R. C. A randomised prospective trial of surgical against medical tetracycline pleurodesis in the management of malignant pleural effusions secondary to breast cancer. Eur J Cancer. 1993;29A(3):316–319. doi: 10.1016/0959-8049(93)90375-p. [DOI] [PubMed] [Google Scholar]
  24. Fentiman I. S., Rubens R. D., Hayward J. L. A comparison of intracavitary talc and tetracycline for the control of pleural effusions secondary to breast cancer. Eur J Cancer Clin Oncol. 1986 Sep;22(9):1079–1081. doi: 10.1016/0277-5379(86)90009-x. [DOI] [PubMed] [Google Scholar]
  25. Fentiman I. S., Rubens R. D., Hayward J. L. Control of pleural effusions in patients with breast cancer. A randomized trial. Cancer. 1983 Aug 15;52(4):737–739. doi: 10.1002/1097-0142(19830815)52:4<737::aid-cncr2820520428>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
  26. Ferrer J., Villarino M. A., Tura J. M., Traveria A., Light R. W. Talc preparations used for pleurodesis vary markedly from one preparation to another. Chest. 2001 Jun;119(6):1901–1905. doi: 10.1378/chest.119.6.1901. [DOI] [PubMed] [Google Scholar]
  27. Foresti V. Intrapleural Corynebacterium parvum for recurrent malignant pleural effusions. Respiration. 1995;62(1):21–26. doi: 10.1159/000196384. [DOI] [PubMed] [Google Scholar]
  28. Fry W. A., Khandekar J. D. Parietal pleurectomy for malignant pleural effusion. Ann Surg Oncol. 1995 Mar;2(2):160–164. doi: 10.1007/BF02303632. [DOI] [PubMed] [Google Scholar]
  29. Gilkeson R. C., Silverman P., Haaga J. R. Using urokinase to treat malignant pleural effusions. AJR Am J Roentgenol. 1999 Sep;173(3):781–783. doi: 10.2214/ajr.173.3.10470923. [DOI] [PubMed] [Google Scholar]
  30. Godley P. J., Bell R. C. Major hemorrhage following administration of intrapleural streptokinase. Chest. 1984 Sep;86(3):486–487. doi: 10.1378/chest.86.3.486. [DOI] [PubMed] [Google Scholar]
  31. Goff B. A., Mueller P. R., Muntz H. G., Rice L. W. Small chest-tube drainage followed by bleomycin sclerosis for malignant pleural effusions. Obstet Gynecol. 1993 Jun;81(6):993–996. [PubMed] [Google Scholar]
  32. Goldman C. A., Skinnider L. F., Maksymiuk A. W. Interferon instillation for malignant pleural effusions. Ann Oncol. 1993 Feb;4(2):141–145. doi: 10.1093/oxfordjournals.annonc.a058416. [DOI] [PubMed] [Google Scholar]
  33. Gravelyn T. R., Michelson M. K., Gross B. H., Sitrin R. G. Tetracycline pleurodesis for malignant pleural effusions. A 10-year retrospective study. Cancer. 1987 Jun 1;59(11):1973–1977. doi: 10.1002/1097-0142(19870601)59:11<1973::aid-cncr2820591124>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
  34. Groth G., Gatzemeier U., Häussingen K., Heckmayr M., Magnussen H., Neuhauss R., Pavel J. V. Intrapleural palliative treatment of malignant pleural effusions with mitoxantrone versus placebo (pleural tube alone). Ann Oncol. 1991 Mar;2(3):213–215. doi: 10.1093/oxfordjournals.annonc.a057908. [DOI] [PubMed] [Google Scholar]
  35. Harris R. J., Kavuru M. S., Rice T. W., Kirby T. J. The diagnostic and therapeutic utility of thoracoscopy. A review. Chest. 1995 Sep;108(3):828–841. doi: 10.1378/chest.108.3.828. [DOI] [PubMed] [Google Scholar]
  36. Hartman D. L., Gaither J. M., Kesler K. A., Mylet D. M., Brown J. W., Mathur P. N. Comparison of insufflated talc under thoracoscopic guidance with standard tetracycline and bleomycin pleurodesis for control of malignant pleural effusions. J Thorac Cardiovasc Surg. 1993 Apr;105(4):743–748. [PubMed] [Google Scholar]
  37. Hatta T., Tsubota N., Yoshimura M., Yanagawa M. [Intrapleural minocycline for postoperative air leakage and control of malignant pleural effusion]. Kyobu Geka. 1990 Apr;43(4):283–286. [PubMed] [Google Scholar]
  38. Hausheer F. H., Yarbro J. W. Diagnosis and treatment of malignant pleural effusion. Semin Oncol. 1985 Mar;12(1):54–75. [PubMed] [Google Scholar]
  39. Heffner J. E., Standerfer R. J., Torstveit J., Unruh L. Clinical efficacy of doxycycline for pleurodesis. Chest. 1994 Jun;105(6):1743–1747. doi: 10.1378/chest.105.6.1743. [DOI] [PubMed] [Google Scholar]
  40. Hsu C. Cytologic detection of malignancy in pleural effusion: a review of 5,255 samples from 3,811 patients. Diagn Cytopathol. 1987 Mar;3(1):8–12. doi: 10.1002/dc.2840030103. [DOI] [PubMed] [Google Scholar]
  41. Hsu W. H., Chiang C. D., Chen C. Y., Kwan P. C., Hsu J. Y. Ultrasound-guided small-bore Elecath tube insertion for the rapid sclerotherapy of malignant pleural effusion. Jpn J Clin Oncol. 1998 Mar;28(3):187–191. doi: 10.1093/jjco/28.3.187. [DOI] [PubMed] [Google Scholar]
  42. Izbicki R., Weyhing B. T., 3rd, Baker L., Caoili E. M., Vaitkevicius V. K. Pleural effusion in cancer patients. A prospective randomized study of pleural drainage with the addition of radioactive phsophorous to the pleural space vs. pleural drainage alone. Cancer. 1975 Oct;36(4):1511–1518. doi: 10.1002/1097-0142(197510)36:4<1511::aid-cncr2820360445>3.0.co;2-7. [DOI] [PubMed] [Google Scholar]
  43. Jerjes-Sánchez C., Ramirez-Rivera A., Elizalde J. J., Delgado R., Cicero R., Ibarra-Perez C., Arroliga A. C., Padua A., Portales A., Villarreal A. Intrapleural fibrinolysis with streptokinase as an adjunctive treatment in hemothorax and empyema: a multicenter trial. Chest. 1996 Jun;109(6):1514–1519. doi: 10.1378/chest.109.6.1514. [DOI] [PubMed] [Google Scholar]
  44. Johnston W. W. The malignant pleural effusion. A review of cytopathologic diagnoses of 584 specimens from 472 consecutive patients. Cancer. 1985 Aug 15;56(4):905–909. doi: 10.1002/1097-0142(19850815)56:4<905::aid-cncr2820560435>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
  45. Jones F. L., Jr Subcutaneous implantation of cancer: a rare complication of pleural biopsy. Chest. 1970 Feb;57(2):189–190. doi: 10.1378/chest.57.2.189. [DOI] [PubMed] [Google Scholar]
  46. Kennedy L., Rusch V. W., Strange C., Ginsberg R. J., Sahn S. A. Pleurodesis using talc slurry. Chest. 1994 Aug;106(2):342–346. doi: 10.1378/chest.106.2.342. [DOI] [PubMed] [Google Scholar]
  47. Kessinger A., Wigton R. S. Intracavitary bleomycin and tetracycline in the management of malignant pleural effusions: a randomized study. J Surg Oncol. 1987 Oct;36(2):81–83. doi: 10.1002/jso.2930360202. [DOI] [PubMed] [Google Scholar]
  48. Kraft A., Weindel K., Ochs A., Marth C., Zmija J., Schumacher P., Unger C., Marmé D., Gastl G. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease. Cancer. 1999 Jan 1;85(1):178–187. [PubMed] [Google Scholar]
  49. Kumar U. N., Varkey B. Case report: subcutaneous metastasis. Rare complication of drainage of malignant pleural fluid. Postgrad Med. 1976 Nov;60(5):253–255. doi: 10.1080/00325481.1976.11714494. [DOI] [PubMed] [Google Scholar]
  50. Lambert C. J., Shah H. H., Urshel H. C., Jr, Paulson D. L. The treatment of malignant pleural effusions by closed trocar tube drainage. Ann Thorac Surg. 1967 Jan;3(1):1–5. doi: 10.1016/s0003-4975(10)66681-7. [DOI] [PubMed] [Google Scholar]
  51. Landvater L., Hix W. R., Mills M., Siegel R. S., Aaron B. L. Malignant pleural effusion treated by tetracycline sclerotherapy. A comparison of single vs repeated instillation. Chest. 1988 Jun;93(6):1196–1198. doi: 10.1378/chest.93.6.1196. [DOI] [PubMed] [Google Scholar]
  52. Leahy B. C., Honeybourne D., Brear S. G., Carroll K. B., Thatcher N., Stretton T. B. Treatment of malignant pleural effusions with intrapleural Corynebacterium parvum or tetracycline. Eur J Respir Dis. 1985 Jan;66(1):50–54. [PubMed] [Google Scholar]
  53. Lee K. A., Harvey J. C., Reich H., Beattie E. J. Management of malignant pleural effusions with pleuroperitoneal shunting. J Am Coll Surg. 1994 Jun;178(6):586–588. [PubMed] [Google Scholar]
  54. Lissoni P., Barni S., Tancini G., Ardizzoia A., Tisi E., Angeli M., Rizzi A. Intracavitary therapy of neoplastic effusions with cytokines: comparison among interferon alpha, beta and interleukin-2. Support Care Cancer. 1995 Jan;3(1):78–80. doi: 10.1007/BF00343925. [DOI] [PubMed] [Google Scholar]
  55. Little A. G., Ferguson M. K., Golomb H. M., Hoffman P. C., Vogelzang N. J., Skinner D. B. Pleuroperitoneal shunting for malignant pleural effusions. Cancer. 1986 Dec 15;58(12):2740–2743. doi: 10.1002/1097-0142(19861215)58:12<2740::aid-cncr2820581231>3.0.co;2-o. [DOI] [PubMed] [Google Scholar]
  56. Loddenkemper R. Thoracoscopy--state of the art. Eur Respir J. 1998 Jan;11(1):213–221. doi: 10.1183/09031936.98.11010213. [DOI] [PubMed] [Google Scholar]
  57. Lorch D. G., Gordon L., Wooten S., Cooper J. F., Strange C., Sahn S. A. Effect of patient positioning on distribution of tetracycline in the pleural space during pleurodesis. Chest. 1988 Mar;93(3):527–529. doi: 10.1378/chest.93.3.527. [DOI] [PubMed] [Google Scholar]
  58. Maher G. G., Berger H. W. Massive pleural effusion: malignant and nonmalignant causes in 46 patients. Am Rev Respir Dis. 1972 Mar;105(3):458–460. doi: 10.1164/arrd.1972.105.3.458. [DOI] [PubMed] [Google Scholar]
  59. Mahfood S., Hix W. R., Aaron B. L., Blaes P., Watson D. C. Reexpansion pulmonary edema. Ann Thorac Surg. 1988 Mar;45(3):340–345. doi: 10.1016/s0003-4975(10)62480-0. [DOI] [PubMed] [Google Scholar]
  60. Marom E. M., Patz E. F., Jr, Erasmus J. J., McAdams H. P., Goodman P. C., Herndon J. E. Malignant pleural effusions: treatment with small-bore-catheter thoracostomy and talc pleurodesis. Radiology. 1999 Jan;210(1):277–281. doi: 10.1148/radiology.210.1.r99dc04277. [DOI] [PubMed] [Google Scholar]
  61. Martini N., Bains M. S., Beattie E. J., Jr Indications for pleurectomy in malignant effusion. Cancer. 1975 Mar;35(3):734–738. doi: 10.1002/1097-0142(197503)35:3<734::aid-cncr2820350328>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  62. Martínez-Moragón E., Aparicio J., Rogado M. C., Sanchis J., Sanchis F., Gil-Suay V. Pleurodesis in malignant pleural effusions: a randomized study of tetracycline versus bleomycin. Eur Respir J. 1997 Oct;10(10):2380–2383. doi: 10.1183/09031936.97.10102383. [DOI] [PubMed] [Google Scholar]
  63. Masotti A., Fumagalli L., Morandini G. C. Intrapleural administration of recombinant interleukin-2 in non-small cell lung cancer with neoplastic pleural effusion. Monaldi Arch Chest Dis. 1997 Jun;52(3):225–228. [PubMed] [Google Scholar]
  64. McAlpine L. G., Hulks G., Thomson N. C. Management of recurrent malignant pleural effusion in the United Kingdom: survey of clinical practice. Thorax. 1990 Sep;45(9):699–701. doi: 10.1136/thx.45.9.699. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. McLeod D. T., Calverley P. M., Millar J. W., Horne N. W. Further experience of Corynebacterium parvum in malignant pleural effusion. Thorax. 1985 Jul;40(7):515–518. doi: 10.1136/thx.40.7.515. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Menzies R., Charbonneau M. Thoracoscopy for the diagnosis of pleural disease. Ann Intern Med. 1991 Feb 15;114(4):271–276. doi: 10.7326/0003-4819-114-4-271. [DOI] [PubMed] [Google Scholar]
  67. Meyer P. C. Metastatic carcinoma of the pleura. Thorax. 1966 Sep;21(5):437–443. doi: 10.1136/thx.21.5.437. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Millar J. W., Hunter A. M., Horne N. W. Intrapleural immunotherapy with Corynebacterium parvum in recurrent malignant pleural effusions. Thorax. 1980 Nov;35(11):856–858. doi: 10.1136/thx.35.11.856. [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Miserocchi G. Physiology and pathophysiology of pleural fluid turnover. Eur Respir J. 1997 Jan;10(1):219–225. doi: 10.1183/09031936.97.10010219. [DOI] [PubMed] [Google Scholar]
  70. Miserocchi G., Venturoli D., Negrini D., Gilardi M. C., Bellina R. Intrapleural fluid movements described by a porous flow model. J Appl Physiol (1985) 1992 Dec;73(6):2511–2516. doi: 10.1152/jappl.1992.73.6.2511. [DOI] [PubMed] [Google Scholar]
  71. Morales M., Expósito M. C. Intrapleural mitoxantrone for the palliative treatment of malignant pleural effusions. Support Care Cancer. 1995 Mar;3(2):147–149. doi: 10.1007/BF00365856. [DOI] [PubMed] [Google Scholar]
  72. Morrison M. C., Mueller P. R., Lee M. J., Saini S., Brink J. A., Dawson S. L., Cortell E. D., Hahn P. F. Sclerotherapy of malignant pleural effusion through sonographically placed small-bore catheters. AJR Am J Roentgenol. 1992 Jan;158(1):41–43. doi: 10.2214/ajr.158.1.1370073. [DOI] [PubMed] [Google Scholar]
  73. Månsson T. Treatment of malignant pleural effusion with doxycycline. Scand J Infect Dis Suppl. 1988;53:29–34. [PubMed] [Google Scholar]
  74. Nakamura H., Ishizaka A., Sawafuji M., Urano T., Fujishima S., Sakamaki F., Sayama K., Kawamura M., Kato R., Kikuchi K. Elevated levels of interleukin-8 and leukotriene B4 in pulmonary edema fluid of a patient with reexpansion pulmonary edema. Am J Respir Crit Care Med. 1994 Apr;149(4 Pt 1):1037–1040. doi: 10.1164/ajrccm.149.4.8143038. [DOI] [PubMed] [Google Scholar]
  75. Negrini D., Pistolesi M., Miniati M., Bellina R., Giuntini C., Miserocchi G. Regional protein absorption rates from the pleural cavity in dogs. J Appl Physiol (1985) 1985 Jun;58(6):2062–2067. doi: 10.1152/jappl.1985.58.6.2062. [DOI] [PubMed] [Google Scholar]
  76. Ostrowski M. J., Halsall G. M. Intracavitary bleomycin in the management of malignant effusions: a multicenter study. Cancer Treat Rep. 1982 Nov;66(11):1903–1907. [PubMed] [Google Scholar]
  77. Ostrowski M. J., Priestman T. J., Houston R. F., Martin W. M. A randomized trial of intracavitary bleomycin and Corynebacterium parvum in the control of malignant pleural effusions. Radiother Oncol. 1989 Jan;14(1):19–26. doi: 10.1016/0167-8140(89)90004-2. [DOI] [PubMed] [Google Scholar]
  78. Owen S., Gould D. Underwater seal chest drains: the patient's experience. J Clin Nurs. 1997 May;6(3):215–225. [PubMed] [Google Scholar]
  79. Parker L. A., Charnock G. C., Delany D. J. Small bore catheter drainage and sclerotherapy for malignant pleural effusions. Cancer. 1989 Sep 15;64(6):1218–1221. doi: 10.1002/1097-0142(19890915)64:6<1218::aid-cncr2820640609>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  80. Patz E. F., Jr, McAdams H. P., Erasmus J. J., Goodman P. C., Culhane D. K., Gilkeson R. C., Herndon J. Sclerotherapy for malignant pleural effusions: a prospective randomized trial of bleomycin vs doxycycline with small-bore catheter drainage. Chest. 1998 May;113(5):1305–1311. doi: 10.1378/chest.113.5.1305. [DOI] [PubMed] [Google Scholar]
  81. Patz E. F., Jr, McAdams H. P., Goodman P. C., Blackwell S., Crawford J. Ambulatory sclerotherapy for malignant pleural effusions. Radiology. 1996 Apr;199(1):133–135. doi: 10.1148/radiology.199.1.8633136. [DOI] [PubMed] [Google Scholar]
  82. Petrou M., Kaplan D., Goldstraw P. Management of recurrent malignant pleural effusions. The complementary role talc pleurodesis and pleuroperitoneal shunting. Cancer. 1995 Feb 1;75(3):801–805. doi: 10.1002/1097-0142(19950201)75:3<801::aid-cncr2820750309>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  83. Prevost A., Nazeyrollas P., Milosevic D., Fernandez-Valoni A. Malignant pleural effusions treated with high dose intrapleural doxycycline: clinical efficacy and tolerance. Oncol Rep. 1998 Mar-Apr;5(2):363–366. doi: 10.3892/or.5.2.363. [DOI] [PubMed] [Google Scholar]
  84. Pulsiripunya C., Youngchaiyud P., Pushpakom R., Maranetra N., Nana A., Charoenratanakul S. The efficacy of doxycycline as a pleural sclerosing agent in malignant pleural effusion: a prospective study. Respirology. 1996 Mar;1(1):69–72. doi: 10.1111/j.1440-1843.1996.tb00013.x. [DOI] [PubMed] [Google Scholar]
  85. Putnam J. B., Jr, Light R. W., Rodriguez R. M., Ponn R., Olak J., Pollak J. S., Lee R. B., Payne D. K., Graeber G., Kovitz K. L. A randomized comparison of indwelling pleural catheter and doxycycline pleurodesis in the management of malignant pleural effusions. Cancer. 1999 Nov 15;86(10):1992–1999. [PubMed] [Google Scholar]
  86. Rinaldo J. E., Owens G. R., Rogers R. M. Adult respiratory distress syndrome following intrapleural instillation of talc. J Thorac Cardiovasc Surg. 1983 Apr;85(4):523–526. [PubMed] [Google Scholar]
  87. Robinson L. A., Fleming W. H., Galbraith T. A. Intrapleural doxycycline control of malignant pleural effusions. Ann Thorac Surg. 1993 May;55(5):1115–1122. doi: 10.1016/0003-4975(93)90017-c. [DOI] [PubMed] [Google Scholar]
  88. Rodriguez-Panadero F., Segado A., Martin Juan J., Ayerbe R., Torres Garcia I., Castillo J. Failure of talc pleurodesis is associated with increased pleural fibrinolysis. Am J Respir Crit Care Med. 1995 Mar;151(3 Pt 1):785–790. doi: 10.1164/ajrccm/151.3_Pt_1.785. [DOI] [PubMed] [Google Scholar]
  89. Rodrîguez-Panadero F., Borderas Naranjo F., López Mejîas J. Pleural metastatic tumours and effusions. Frequency and pathogenic mechanisms in a post-mortem series. Eur Respir J. 1989 Apr;2(4):366–369. [PubMed] [Google Scholar]
  90. Rosso R., Rimoldi R., Salvati F., De Palma M., Cinquegrana A., Nicolò G., Ardizzoni A., Fusco U., Capaccio A., Centofanti R. Intrapleural natural beta interferon in the treatment of malignant pleural effusions. Oncology. 1988;45(3):253–256. doi: 10.1159/000226571. [DOI] [PubMed] [Google Scholar]
  91. Ruckdeschel J. C., Moores D., Lee J. Y., Einhorn L. H., Mandelbaum I., Koeller J., Weiss G. R., Losada M., Keller J. H. Intrapleural therapy for malignant pleural effusions. A randomized comparison of bleomycin and tetracycline. Chest. 1991 Dec;100(6):1528–1535. doi: 10.1378/chest.100.6.1528. [DOI] [PubMed] [Google Scholar]
  92. Rusch V. W., Figlin R., Godwin D., Piantadosi S. Intrapleural cisplatin and cytarabine in the management of malignant pleural effusions: a Lung Cancer Study Group trial. J Clin Oncol. 1991 Feb;9(2):313–319. doi: 10.1200/JCO.1991.9.2.313. [DOI] [PubMed] [Google Scholar]
  93. Sahn S. A. Pleural diseases related to metastatic malignancies. Eur Respir J. 1997 Aug;10(8):1907–1913. doi: 10.1183/09031936.97.10081907. [DOI] [PubMed] [Google Scholar]
  94. Salyer W. R., Eggleston J. C., Erozan Y. S. Efficacy of pleural needle biopsy and pleural fluid cytopathology in the diagnosis of malignant neoplasm involving the pleura. Chest. 1975 May;67(5):536–539. doi: 10.1378/chest.67.5.536. [DOI] [PubMed] [Google Scholar]
  95. Sears D., Hajdu S. I. The cytologic diagnosis of malignant neoplasms in pleural and peritoneal effusions. Acta Cytol. 1987 Mar-Apr;31(2):85–97. [PubMed] [Google Scholar]
  96. Seaton K. G., Patz E. F., Jr, Goodman P. C. Palliative treatment of malignant pleural effusions: value of small-bore catheter thoracostomy and doxycycline sclerotherapy. AJR Am J Roentgenol. 1995 Mar;164(3):589–591. doi: 10.2214/ajr.164.3.7532350. [DOI] [PubMed] [Google Scholar]
  97. Sherman S., Grady K. J., Seidman J. C. Clinical experience with tetracycline pleurodesis of malignant pleural effusions. South Med J. 1987 Jun;80(6):716–719. doi: 10.1097/00007611-198706000-00013. [DOI] [PubMed] [Google Scholar]
  98. Sørensen P. G., Svendsen T. L., Enk B. Treatment of malignant pleural effusion with drainage, with and without instillation of talc. Eur J Respir Dis. 1984 Feb;65(2):131–135. [PubMed] [Google Scholar]
  99. Tarver R. D., Broderick L. S., Conces D. J., Jr Reexpansion pulmonary edema. J Thorac Imaging. 1996 Summer;11(3):198–209. [PubMed] [Google Scholar]
  100. Thompson R. L., Yau J. C., Donnelly R. F., Gowan D. J., Matzinger F. R. Pleurodesis with iodized talc for malignant effusions using pigtail catheters. Ann Pharmacother. 1998 Jul-Aug;32(7-8):739–742. doi: 10.1345/aph.17435. [DOI] [PubMed] [Google Scholar]
  101. Tillett W. S., Sherry S. THE EFFECT IN PATIENTS OF STREPTOCOCCAL FIBRINOLYSIN (STREPTOKINASE) AND STREPTOCOCCAL DESOXYRIBONUCLEASE ON FIBRINOUS, PURULENT, AND SANGUINOUS PLEURAL EXUDATIONS. J Clin Invest. 1949 Jan;28(1):173–190. doi: 10.1172/JCI102046. [DOI] [PMC free article] [PubMed] [Google Scholar]
  102. Viallat J. R., Boutin C., Rey F., Astoul P., Farisse P., Brandely M. Intrapleural immunotherapy with escalating doses of interleukin-2 in metastatic pleural effusions. Cancer. 1993 Jun 15;71(12):4067–4071. doi: 10.1002/1097-0142(19930615)71:12<4067::aid-cncr2820711243>3.0.co;2-d. [DOI] [PubMed] [Google Scholar]
  103. Viallat J. R., Rey F., Astoul P., Boutin C. Thoracoscopic talc poudrage pleurodesis for malignant effusions. A review of 360 cases. Chest. 1996 Dec;110(6):1387–1393. doi: 10.1378/chest.110.6.1387. [DOI] [PubMed] [Google Scholar]
  104. Villanueva A. G., Gray A. W., Jr, Shahian D. M., Williamson W. A., Beamis J. F., Jr Efficacy of short term versus long term tube thoracostomy drainage before tetracycline pleurodesis in the treatment of malignant pleural effusions. Thorax. 1994 Jan;49(1):23–25. doi: 10.1136/thx.49.1.23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  105. Viskum K., Enk B. Complications of thoracoscopy. Poumon Coeur. 1981 Jan-Feb;37(1):25–28. [PubMed] [Google Scholar]
  106. Waller D. A., Morritt G. N., Forty J. Video-assisted thoracoscopic pleurectomy in the management of malignant pleural effusion. Chest. 1995 May;107(5):1454–1456. doi: 10.1378/chest.107.5.1454. [DOI] [PubMed] [Google Scholar]
  107. Webb H. E., Oaten S. W., Pike C. P. Treatment of malignant ascitic and pleural effusion with Corynebacterium parvum. Br Med J. 1978 Feb 11;1(6109):338–340. doi: 10.1136/bmj.1.6109.338. [DOI] [PMC free article] [PubMed] [Google Scholar]
  108. Webb W. R., Ozmen V., Moulder P. V., Shabahang B., Breaux J. Iodized talc pleurodesis for the treatment of pleural effusions. J Thorac Cardiovasc Surg. 1992 May;103(5):881–886. [PubMed] [Google Scholar]
  109. Weissberg D., Ben-Zeev I. Talc pleurodesis. Experience with 360 patients. J Thorac Cardiovasc Surg. 1993 Oct;106(4):689–695. [PubMed] [Google Scholar]
  110. Wilkins H. E., 3rd, Connolly M. M., Grays P., Marquez G., Nelson D. Recombinant interferon alpha-2b in the management of malignant pleural effusions. Chest. 1997 Jun;111(6):1597–1599. doi: 10.1378/chest.111.6.1597. [DOI] [PubMed] [Google Scholar]
  111. Wong P. S., Goldstraw P. Pleuroperitoneal shunts. 1993 Jun 16-Jul 13Br J Hosp Med. 50(1):16–21. [PubMed] [Google Scholar]
  112. Wooten S. A., Barbarash R. A., Strange C., Sahn S. A. Systemic absorption of tetracycline and lidocaine following intrapleural instillation. Chest. 1988 Nov;94(5):960–963. doi: 10.1378/chest.94.5.960. [DOI] [PubMed] [Google Scholar]
  113. Xie C., Teixeira L. R., McGovern J. P., Light R. W. Systemic corticosteroids decrease the effectiveness of talc pleurodesis. Am J Respir Crit Care Med. 1998 May;157(5 Pt 1):1441–1444. doi: 10.1164/ajrccm.157.5.9708032. [DOI] [PubMed] [Google Scholar]
  114. Yim A. P., Chan A. T., Lee T. W., Wan I. Y., Ho J. K. Thoracoscopic talc insufflation versus talc slurry for symptomatic malignant pleural effusion. Ann Thorac Surg. 1996 Dec;62(6):1655–1658. [PubMed] [Google Scholar]
  115. Yim A. P., Chung S. S., Lee T. W., Lam C. K., Ho J. K. Thoracoscopic management of malignant pleural effusions. Chest. 1996 May;109(5):1234–1238. doi: 10.1378/chest.109.5.1234. [DOI] [PubMed] [Google Scholar]
  116. Yim A. P., Chung S. S., Lee T. W., Lam C. K., Ho J. K. Thoracoscopic management of malignant pleural effusions. Chest. 1996 May;109(5):1234–1238. doi: 10.1378/chest.109.5.1234. [DOI] [PubMed] [Google Scholar]
  117. Yim A. P. Port-site recurrence following video-assisted thoracoscopic surgery. Surg Endosc. 1995 Oct;9(10):1133–1135. doi: 10.1007/BF00189005. [DOI] [PubMed] [Google Scholar]
  118. Zaloznik A. J., Oswald S. G., Langin M. Intrapleural tetracycline in malignant pleural effusions. A randomized study. Cancer. 1983 Feb 15;51(4):752–755. doi: 10.1002/1097-0142(19830215)51:4<752::aid-cncr2820510434>3.0.co;2-7. [DOI] [PubMed] [Google Scholar]
  119. Zimmer P. W., Hill M., Casey K., Harvey E., Low D. E. Prospective randomized trial of talc slurry vs bleomycin in pleurodesis for symptomatic malignant pleural effusions. Chest. 1997 Aug;112(2):430–434. doi: 10.1378/chest.112.2.430. [DOI] [PubMed] [Google Scholar]
  120. de Campos J. R., Vargas F. S., de Campos Werebe E., Cardoso P., Teixeira L. R., Jatene F. B., Light R. W. Thoracoscopy talc poudrage : a 15-year experience. Chest. 2001 Mar;119(3):801–806. doi: 10.1378/chest.119.3.801. [DOI] [PubMed] [Google Scholar]
  121. van de Molengraft F. J., Vooijs G. P. Survival of patients with malignancy-associated effusions. Acta Cytol. 1989 Nov-Dec;33(6):911–916. [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES